紐澤西 的 頭頸部鱗狀細胞癌 臨床試驗
26 項針對 頭頸部鱗狀細胞癌 的研究正在 紐澤西 各地點尋找參與者。
紐澤西 的城市
官方研究文本（英文）
High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer
- Jefferson Cherry Hill Hospital, Cherry Hill
- Sidney Kimmel Cancer Center Washington Township, Sewell
招募中3 期
18 歲及以上 · 所有性別 · 更新於 2026年10月2日 · NCT06992427FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC
- Hackensack Meridian Health (Site # 119), Hackensack
- Site #0145, Newark
招募中2/3 期
18 歲及以上 · 所有性別 · 更新於 2026年10月2日 · NCT06788990Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
- Exelixis Clinical Site #88, East Brunswick
- Exelixis Clinical Site #105, Hackensack
招募中1 期
18 歲及以上 · 所有性別 · 更新於 2026年10月1日 · NCT05176483Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment
- Memorial Sloan Kettering Basking Ridge, Basking Ridge
- Memorial Sloan Kettering Monmouth, Middletown
- Memorial Sloan Kettering Bergen, Montvale
招募中3 期
18 歲及以上 · 所有性別 · 更新於 2026年10月1日 · NCT06589804A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
- ALX Center 12, Morristown
招募中1 期
18 歲及以上 · 所有性別 · 更新於 2026年9月30日 · NCT07085091A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
- Research Site, New Brunswick
招募中1 期
18 歲及以上 · 所有性別 · 更新於 2026年9月29日 · NCT05877599A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
- Rutgers Cancer Institute of New Jersey, New Brunswick
招募中3 期
18 歲及以上 · 所有性別 · 更新於 2026年9月25日 · NCT07276399A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Head and Neck Cancer
- Rutgers Cancer Institute of New Jersey, New Brunswick
招募中1/2 期
18 歲及以上 · 所有性別 · 更新於 2026年9月25日 · NCT06385080Testing Whether Cemiplimab (REGN2810) Plus CDX-1140 Given Prior to Surgery Are Better Than Cemiplimab (REGN2810) Alone in Patients With Stage III-IV Head and Neck Cancer
- Hackensack University Medical Center, Hackensack
招募中2 期
18 歲及以上 · 所有性別 · 更新於 2026年9月25日 · NCT06980038Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma
- Memorial Sloan Kettering Basking Ridge, Basking Ridge
- Memorial Sloan Kettering Monmouth, Middletown
- Memorial Sloan Kettering Bergen, Montvale
招募中2 期
18 至 79 歲 · 所有性別 · 更新於 2026年9月22日 · NCT04671667ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
- Astera Cancer Care, East Brunswick
招募中觀察性研究
18 歲及以上 · 所有性別 · 更新於 2026年9月14日 · NCT05059444Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
- Jersey City Medical Center, Jersey City
- Cooperman Barnabas Medical Center, Livingston
- Monmouth Medical Center, Long Branch
- 還有 5 項
招募中2 期
18 歲及以上 · 所有性別 · 更新於 2026年9月14日 · NCT02734537A Phase 1 Study of EPI-326 in EGFR-mutant NSCLC and HNSCC
- Site 104 - START New Jersey, East Brunswick
招募中1 期
18 歲及以上 · 所有性別 · 更新於 2026年9月10日 · NCT07462377A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
- Normunity Investigational Site, Hackensack
招募中1 期
18 歲及以上 · 所有性別 · 更新於 2026年8月18日 · NCT07182149Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer
- Memorial Sloan Kettering Basking Ridge, Basking Ridge
- Saint Barnabas Medical Center, Livingston
- Memorial Sloan Kettering Monmouth, Middletown
- 還有 2 項
招募中2/3 期
18 歲及以上 · 所有性別 · 更新於 2026年8月17日 · NCT04333537A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
- John Theurer Cancer Center, Hackensack
招募中1/2 期
18 歲及以上 · 所有性別 · 更新於 2026年8月17日 · NCT04895709A Study of Decreasing Radiation Therapy and Chemotherapy in People With Head and Neck Cancer
- Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown
- Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale
招募中2 期
18 歲及以上 · 所有性別 · 更新於 2026年8月12日 · NCT05544136A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge
- Memorial Sloan Kettering Monmouth (Limited protocol activities), Middletown
- Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale
招募中1 期
18 歲及以上 · 所有性別 · 更新於 2026年8月12日 · NCT05859074The Sinai Robotic Surgery Trial in HPV-related Oropharyngeal Squamous Cell Carcinoma (SIRS 2.0 Trial)
- Valley - Mount Sinai Comprehensive Cancer Care, Paramus
招募中2 期
18 歲及以上 · 所有性別 · 更新於 2026年7月22日 · NCT05419089A Study of Cemiplimab With Chemotherapy and Immunotherapy in People With Head and Neck Cancer
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown
- Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale
招募中1 期
18 歲及以上 · 所有性別 · 更新於 2026年7月21日 · NCT04722523A Study to Investigate ALE.P02 as Monotherapy in Adult Patients With Selected CLDN1+ Solid Tumors
- Hackensack University Medical Center, Hackensack
招募中1/2 期
18 歲及以上 · 所有性別 · 更新於 2026年6月29日 · NCT06747585A Study of Radiation Therapy After Surgery in People With Oral Tongue Squamous Cell Carcinoma
- Memorial Sloan Kettering Basking Ridge, Basking Ridge
- Memorial Sloan Kettering Monmouth, Middletown
- Memorial Sloan Kettering Bergen, Montvale
招募中2 期
18 歲及以上 · 所有性別 · 更新於 2026年5月29日 · NCT06485778A Study of Sacituzumab Govitecan in Combination With Cetuximab in People With Head and Neck Squamous Cell Cancer (HNSCC)
- Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown
- Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale
招募中2 期
18 歲及以上 · 所有性別 · 更新於 2026年2月19日 · NCT07063212A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
- Hackensack University Medical Center, Hackensack
招募中1 期
18 歲及以上 · 所有性別 · 更新於 2026年2月13日 · NCT06778863VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
- Englewood Hospital and Medical Center (site 202), Englewood
- Summit Medical Group (site 205), Florham Park
- Atlantic Health System, Morristown Medical Center (site 124), Morristown
招募中1/2 期
18 至 80 歲 · 所有性別 · 更新於 2025年12月11日 · NCT03556228RAPA-201 Therapy of Solid Tumors
- Hackensack University Medical Center, Hackensack
招募中1/2 期
18 歲及以上 · 所有性別 · 更新於 2025年5月14日 · NCT05144698資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。